Denosumab Versus Alendronate for Osteoporosis in Patients Receiving Long-Term Glucocorticoids
A study published as part of the American College of Rheumatology Annual Meeting compared denosumab versus alendronate for patients with osteoporosis receiving long-term glucocorticoids...
Physicians Are Not Widely Screening for Osteoporosis in Men
An article published in Endocrine Practice observed heterogeneity in osteoporosis screening patterns in male patients among surveyed primary care physicians, endocrinologists, and geriatricians.
Researchers surveyed...
Should Osteoporosis Medication Be Discontinued During the COVID-19 Pandemic?
A study published in Aging supports the continued use of antiosteoporosis medications during the COVID-19 pandemic, speculating that some of these agents may even...
Rheum Round-up: Blood Test to Guide RA Treatment, COVID’s Osteoporosis Impact, and more
A Blood Test May Help Determine Which Patients with RA Will Respond to Treatment
A new study found that blood biomarkers may be useful in...
Osteoporosis Is Prevalent in Patients with Crohn’s Disease
A systematic review published in World Journal of Gastroenterology observed a possible increased prevalence of osteoporosis in patients with Crohn’s disease compared with patients...
Strategies Needed to Mitigate Osteoporosis Risk in Women with Gynecologic Cancers
A study published in Obstetrics & Gynecology Science found that bone mineral density (BMD) was significantly lower in women with cervical and ovarian cancer...
Celiac Disease Is Associated with Risk of Osteoporotic Fractures
A study published in Osteoporosis International found that celiac disease is associated with major osteoporotic fracture, independent of fracture risk assessment tool (FRAX) score.
The...
